Skip to main content
BIO PROTECH INC. logo

BIO PROTECH INC. — Investor Relations & Filings

Ticker · 199290 ISIN · KR7199290008 LEI · 988400TYKP3J6SZOGR02 KO Manufacturing
Open in API
Filings indexed 281 across all filing types
Latest filing 2021-04-06 Capital/Financing Update
Country KR South Korea
Listing KO 199290

About BIO PROTECH INC.

https://www.protechsite.com/

BIO PROTECH INC. is a manufacturer of medical equipment and disposable supplies. The company develops and produces a range of products for applications in surgery, cardiology, neurology, and pain management. Its portfolio includes electrosurgical devices such as smoke evacuators and surgical pencils, various electrocardiogram (ECG) electrodes, and transcutaneous electrical nerve stimulation (TENS) units. The company specializes in bio-medical sensors and related products developed using advanced skin technology for the global healthcare market.

Recent filings

Filing Released Lang Actions
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 1% confidence The document is a 'Major Report' (주요사항보고서) filed with the Financial Services Commission/Korea Exchange regarding the decision to issue convertible bonds (전환사채권 발행결정). It details the terms of the issuance, including interest rates, conversion prices, and the use of proceeds. This falls under the category of capital and financing updates.
2021-04-06 Korean
증권발행결과(자율공시)(제8회차 CB)
Share Issue/Capital Change Classification · 1% confidence The document is a 'Securities Issuance Result' (증권 발행결과) announcement regarding the issuance of convertible bonds (CB). It details the issuance amount, payment date, and the nature of the securities. This falls under the category of capital and financing updates, specifically related to the issuance of debt instruments that can be converted into equity.
2021-04-06 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is an official announcement of the results of a General Meeting of Shareholders (AGM) for BioProtech, dated 2021-03-31. It details the approval of financial statements, director appointments, and remuneration limits. This falls directly under the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2021-03-31 Korean
대표이사변경
Board/Management Information Classification · 1% confidence The document is a formal announcement regarding a change in the company's representative director (CEO). It explicitly lists the 'before' and 'after' names, the reason for the change, the date of the board resolution, and the biographical details of the new appointee. This falls directly under the definition of a board/management change announcement.
2021-03-31 Korean
기타시장안내(개선기간 종료에 따른 상장폐지 여부 결정 안내)
Delisting Announcement Classification · 1% confidence The document is a regulatory announcement from the Korea Exchange regarding the status of a company's listing (BioProtech) following the expiration of an improvement period and issues related to audit opinions. It does not fit into specific categories like financial reports or shareholder meetings, and it is not a delisting announcement yet, but rather a regulatory notice regarding the process of determining potential delisting. Therefore, it falls under the general regulatory filing category.
2021-03-31 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership, and the purpose of holding (influencing management) for a specific entity, (주)바이오프로테크. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema, as it tracks significant ownership thresholds and changes.
2021-03-26 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.